About Apellis Pharma (APLS)
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more
- USD17.43
- USD17.60
- USD17.15
- USD42.47
- 3.20%
- 776M
- 2.24M
- 2.25M
- 2.2B
- 16.10
- -58.00%
Stock News
yesterday
Jim Cramer explains how younger buyers are driving market action
CNBC
yesterday
Despite tariffs, Andy Jassy says Amazon hasn't 'seen prices appreciably go up,' so far
CNBC
yesterday
Cristiano Ronaldo’s new $700 million contract reportedly includes private-jet credits and personal staff. Here’s how that compares with perks for other top athletes and CEOs.
MarketWatch
yesterday
LGBTQ+ entrepreneurs starting businesses in record numbers
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
